CLOV vs VLTO · rev $1.37B vs P/E 29, rev $5.19B
Clover Health Investments Corp (CLOV) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VLTO revenue for 2024-12-31 was $5.19B. Net income was $833.0M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
CLOV currently screens at market cap $1.55B. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the CLOV and VLTO stock pages for the full models.
Not investment advice.